Smart cancer nanomedicine

R van der Meel, E Sulheim, Y Shi, F Kiessling… - Nature …, 2019 - nature.com
Nanomedicines are extensively employed in cancer therapy. We here propose four strategic
directions to improve nanomedicine translation and exploitation.(1) Patient stratification has …

Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and …

M Perera, N Papa, M Roberts, M Williams, C Udovicich… - European urology, 2020 - Elsevier
Context Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …

E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET

F Ceci, DE Oprea-Lager, L Emmett, JA Adam… - European journal of …, 2021 - Springer
Rationale The development of consensus guidelines for interpretation of Prostate-Specific
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …

Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial

WP Fendler, J Calais, M Eiber, RR Flavell… - JAMA …, 2019 - jamanetwork.com
Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …

Nanoprobe-based molecular imaging for tumor stratification

X Ma, M Mao, J He, C Liang, HY Xie - Chemical Society Reviews, 2023 - pubs.rsc.org
The responses of patients to tumor therapies vary due to tumor heterogeneity. Tumor
stratification has been attracting increasing attention for accurately distinguishing between …

18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm …

J Calais, F Ceci, M Eiber, TA Hope, MS Hofman… - The Lancet …, 2019 - thelancet.com
Summary Background National Comprehensive Cancer Network guidelines consider 18 F-
fluciclovine PET-CT for prostate cancer biochemical recurrence localisation after radical …

Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer

A Farolfi, L Calderoni, F Mattana, R Mei… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer
(PCa) cells, and several PSMA ligands for PET imaging are now available worldwide. 68Ga …

A framework for the development of effective anti-metastatic agents

RL Anderson, T Balasas, J Callaghan… - Nature Reviews …, 2019 - nature.com
Most cancer-related deaths are a result of metastasis, and thus the importance of this
process as a target of therapy cannot be understated. By asking 'how can we effectively treat …

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

WP Fendler, M Eiber, M Beheshti, J Bomanji… - European journal of …, 2023 - Springer
Here we aim to provide updated guidance and standards for the indication, acquisition, and
interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics …

Appropriate use criteria for prostate-specific membrane antigen PET imaging

H Jadvar, J Calais, S Fanti, F Feng… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Prostate cancer is the most common cancer diagnosis in men in the United States and a
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …